Vibrant Ltd.

Vibrant Ltd. , based in Israel, specializes in innovative, drug-free solutions for chronic idiopathic constipation, primarily through its flagship product, the Vibrant Capsule, which enhances colon function effectively and safely. Founded in 2007 and headquartered in Yokneam Illit, Israel, Vibrant Ltd. develops non-invasive treatments for gastrointestinal issues.

The company raised USD 7. 5 mn in Series E funding on March 26, 2021, led by Unorthodox Ventures, with participation from Sequoia Capital. CEO John Schellhorn oversees the company’s strategic direction. Vibrant Gastro develops the Vibrant Capsule, an FDA-cleared product utilizing the Synchronized Activation Method™ to treat chronic idiopathic constipation (CIC).

This capsule stimulates the colon with micro-vibrations, providing relief where traditional laxatives fall short. The company collaborates with specialty pharmacies like EVERSANA to ensure accessibility for patients requiring this treatment. Revenue is generated through prescription sales of the Vibrant Capsule, taken five days a week. The company operates primarily on a B2B model, where healthcare providers prescribe the capsule, which patients obtain through specialty pharmacies, supported by the VibrantConnect team to ensure comprehensive care.

Vibrant Ltd. aims to enhance its product line and explore new markets. The company is currently focused on launching additional products designed for gastrointestinal health. The recent funding of USD 7.

5 mn will be used to support product development and expansion into new geographic markets, enabling more patients to access Vibrant's therapeutic solutions.